Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and antitumor effects of TRAIL in human cholangiocarcinoma.

Hepatology (Baltimore, Md.) - 1 Sept 2000

Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands J R

Abstract excerpt

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/Apo2L has been recently identified as important in promoting programmed cell death in breast and colon adenocarcinomas. In this study, we investigated the expression and therapeutic potential of TRAIL in cholangiocarcinoma, one of the most devastating human hepatic malignancies. Expression of TRAIL receptors was determined in 13 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to Bile Duct Neoplasms
Share to Bile Ducts, Intrahepatic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholangiocarcinoma

Share to Mice, Nude

Share to Neoplasm Transplantation

Share to Receptors, Tumor Necrosis Factor

Share to TNF-Related Apoptosis-Inducing Ligand

Source

Identifiers

PMID: 10960444
DOI: 10.1053/jhep.2000.9716

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and antitumor effects of TRAIL in human cholangiocarcinoma.PMID 10960444Read ↗

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cellsSemantic proximity Read ↗

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in CholangiocarcinomaSemantic proximity Read ↗

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in CholangiocarcinomaSemantic proximity Read ↗

The TRAIL apoptotic pathway in cancer onset, progression and therapy.Semantic proximity Read ↗

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.Semantic proximity Read ↗

IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.Semantic proximity Read ↗

Therapeutic applications of TRAIL receptor agonists in cancer and beyondSemantic proximity Read ↗

TRAIL as a target in anti-cancer therapy.Semantic proximity Read ↗

Fas expression prevents cholangiocarcinoma tumor growth.Semantic proximity Read ↗

Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.Semantic proximity Read ↗

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILSemantic proximity Read ↗

Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell lineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.